FDA Reasserts Dura Mater Device Status During Interim Preceding GTPs

FDA is moving forward with rules establishing human dura mater as a Class II medical device before the agency issues guidelines transitioning the product into the purview of tissue regulation

More from Archive

More from Medtech Insight